Skip to main content
. 2018 Dec 14;97(50):e13555. doi: 10.1097/MD.0000000000013555

Figure 1.

Figure 1

In total, 2787 patients were included in our study. Patients were stratified based on first-line regimen: 364 patients initiated D4T-based ART [D4T/3TC/efavirenz (EFV) or nevirapine (NVP)], 1453 patients initiated AZT-based ART (AZT/3TC/EFV or NVP) and 970 patients initiated TDF-based ART (TDF/3TC/EFV or NVP) from 2011 to 2015.